Tracking thinking and quality of life during migraine prevention
Part of Brain & nervous system, Pain clinical trials.
This study looks at how preventive treatments for severe migraines, like botulinum toxin injections or anti-CGRP antibody infusions, may affect thinking and quality of life. If you have frequent migraines that don't respond to other treatments, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult with severe migraines on 8 or more days per month.
- Your doctor has recommended either botulinum toxin type A injections or an anti-CGRP antibody infusion (like eptinezumab).
- You do not have other chronic pain conditions, neurological disorders, or severe mental health issues other than mild anxiety or depression.
- You are not pregnant or breastfeeding, and do not have any allergies or conditions that would make these treatments unsafe.
- You are able to understand the study and give your consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at ways to help children and teens with migraine headaches by testing a care approach that includes access to evidence-based treatment. It may help if your child has frequent migraine headaches and is starting (or not already on) certain migraine-preventive medicines.
This study compares two treatments for chronic migraine: a nerve block procedure called pulsed radiofrequency (using a special needle to calm nerves in the head) versus Botox injections. The goal is to see which one works better at reducing headache days and pain.
This study uses brain scans (PET) to look at how the body’s “opioid” pain system works in people with migraine. It may help researchers understand migraine biology and test approaches that could improve migraine treatment.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This trial tests whether using both a CGRP antibody and Botox together works better than the CGRP antibody alone for chronic migraine. It may help if you have not tried these treatments before.
This study compares two treatments for chronic migraine: a nerve stimulation procedure called pulsed radiofrequency and Botox injections. Both are known to help some people with chronic migraine, and the goal is to see which one works better at reducing headache days and improving quality of life.
Hear when a new Chronic Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.